AI assistant
CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2024
Nov 13, 2024
31542_dirs_2024-11-13_d43372b6-fe94-4d29-a292-9c741289aba0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2024-11-11
Reporting Person: MCENANY PATRICK J (Director, Chairman of Board of Directors)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-11-11 | Common stock, par value $0.001 per share | M | 230000 | $4.01 | Acquired | 4708169 | Direct |
| 2024-11-11 | Common stock, par value $0.001 per share | S | 230000 | $23.548 | Disposed | 4478169 | Direct |
| 2024-11-12 | Common stock, par value $0.001 per share | M | 70000 | $4.01 | Acquired | 4548169 | Direct |
| 2024-11-12 | Common stock, par value $0.001 per share | S | 70000 | $23.421 | Disposed | 4478169 | Direct |
| 2024-11-12 | Common stock, par value $0.001 per share | M | 192000 | $3.54 | Acquired | 4670169 | Direct |
| 2024-11-12 | Common stock, par value $0.001 per share | S | 192000 | $23.201 | Disposed | 4478169 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-11-11 | Options to purchase common stock | $4.01 | M | 230000 | Disposed | 2025-01-02 | Common Stock (230000) | Direct |
| 2024-11-12 | Options to purchase common stock | $4.01 | M | 70000 | Disposed | 2025-01-02 | Common Stock (70000) | Direct |
| 2024-11-12 | Options to purchase common stock | $3.54 | M | 192000 | Disposed | 2025-05-29 | Common Stock (192000) | Direct |
Footnotes
F1: Shares were sold for personal reasons, including paying federal income taxes and diversifying the Reporting Person's portfolio. Shares were not sold as a result of any disagreement with the Company. Mr. McEnany remains the non-executive chairman of the Company's Board of Directors and the Company's largest individual, non-institutional shareholder.
F2: Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $23.29 to $23.873 per share.
F3: Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $23.30 to $23.50 per share.
F4: Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $23.03 to $23.48 per share.
F5: Options vested in three equal tranches on January 2, 2019, 2020 and 2021.
F6: Options vested in three equal tranches on May 29, 2019, 2020 and 2021.